Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection
Status:
Withdrawn
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
This is a double-blinded, placebo-controlled parallel, phase II clinical efficacy study
evaluating Nitric Oxide Nasal Irrigation (NONI) for the treatment of COVID-19 in individuals
with mild COVID-19 Infection.